Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs. Norethindrone Acetate in Endometriosis
NCT05476172Completed
- Sponsor
- Bursa Uludag University
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dienogest in endometriosis (2 arms), sponsored by Bursa Uludag University. Primary endpoint: Chronic Pelvic Pain Score at 12 months. Started Apr 2021; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05476172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05476172.